Woodward Drug Patent Portfolio
Woodward owns 1 orange book drug protected by 6 US patents Given below is the list of Woodward's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic | 19 Oct, 2020 | Expired |
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic | 19 Apr, 2020 | Expired |
| US6288095 | Compounds | 11 Aug, 2017 | Expired |
| US6288095 | Compounds | 11 Feb, 2017 | Expired |
| US5741803 | Substituted thiazolidinedionle derivatives | 21 Oct, 2015 | Expired |
| US5741803 | Substituted thiazolidinedionle derivatives | 21 Apr, 2015 | Expired |
Latest Legal Activities on Woodward's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Woodward.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 14 May, 2012 | US7358366 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Apr, 2008 | US7358366 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Apr, 2008 | US7358366 |
|
Issue Notification Mailed
Critical
| 26 Mar, 2008 | US7358366 |
| Dispatch to FDC | 17 Mar, 2008 | US7358366 |
|
Response to Amendment under Rule 312
Critical
| 12 Mar, 2008 | US7358366 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 12 Mar, 2008 | US7358366 |
|
Application Is Considered Ready for Issue
Critical
| 05 Mar, 2008 | US7358366 |
|
Amendment after Notice of Allowance (Rule 312)
Critical
| 22 Feb, 2008 | US7358366 |
|
Issue Fee Payment Received
Critical
| 22 Feb, 2008 | US7358366 |
|
Issue Fee Payment Verified
Critical
| 22 Feb, 2008 | US7358366 |
|
Mail Notice of Allowance
Critical
| 23 Nov, 2007 | US7358366 |
|
Notice of Allowance Data Verification Completed
Critical
| 20 Nov, 2007 | US7358366 |
| Date Forwarded to Examiner | 17 Nov, 2007 | US7358366 |
|
Response after Non-Final Action
Critical
| 05 Oct, 2007 | US7358366 |
Woodward's Family Patents
Woodward Drug List
Given below is the complete list of Woodward's drugs and the patents protecting them.
1. Avandia
Avandia is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7358366
(Pediatric)
| Thiazolidinedione derivative and its use as antidiabetic |
19 Oct, 2020
(5 years ago)
| Expired |
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
19 Apr, 2020
(5 years ago)
| Expired |
| US6288095
(Pediatric)
| Compounds |
11 Aug, 2017
(8 years ago)
| Expired |
| US6288095 | Compounds |
11 Feb, 2017
(8 years ago)
| Expired |
| US5741803
(Pediatric)
| Substituted thiazolidinedionle derivatives |
21 Oct, 2015
(10 years ago)
| Expired |
| US5741803 | Substituted thiazolidinedionle derivatives |
21 Apr, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avandia's drug page